Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN

Conclusions:
Combination of fingolimod with antidepressant medication showed no unexpected safety signals. Patient-reported outcomes (QoL, disability, fatigue and depression) remained stable or improved.

Source: Therapeutic Advances in Neurological Disorders - August 14, 2016 Category: Neurology Authors: Bayas, A., Schuh, K., Baier, M., Vormfelde, S. V., for the REGAIN Study Group, Koppai-Reiner, Strauss, Haerting, Wiehler, Boehringer, Laumen, Christopher, Pfeiffer, Hofmann, Horn, Lauter, Polzer, Halbgewachs, Siever, Honig, Mahler, Kuhlgert, Weber, Bischo Tags: Original Research Source Type: research